Safety and Efficacy of Semorinemab in Individuals with Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial

Edmond Teng*, Paul T. Manser, Karen Pickthorn, Flavia Brunstein, Mira Blendstrup, Sandra Sanabria Bohorquez, Kristin R. Wildsmith, Bali Toth, Michael Dolton, Vidya Ramakrishnan, Ashwini Bobbala, Sietske A.M. Sikkes, Michael Ward, Reina N. Fuji, Geoffrey A. Kerchner

*Corresponding author for this work

Research output: Contribution to Journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Safety and Efficacy of Semorinemab in Individuals with Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science